RANBAXY LABS BUYOUT OF PRX

[Anonymous]

It becomes so obvious when you compare the super generous par employee benefits to the new employees coming over from edict anchen pharmas

Le pore is so slow to act but he finally gets it

a

it is long overdue and saves our jobs

 

[Anonymous]

We have no problem with giving up the christmas shutdown if that is what it takes to get us profitable

After all adam and the other managers work and work hard during that holiday furlough

Givebacks to save jobs in generics - sign me up

 

[Anonymous]

Givebacks to save jobs in generics - sign me up

Some jerk wants welfare from strativa, which is broke


Get lost. No goal

 

[Anonymous]

Rumors of sale of strativa are flourishing. Nice uptick in megace sales acc to ML
should add to the sales price. Pl insisting that adam retain a lead sales position
upon sale although rp's fate is uncertain.

I heard that Strativa will fetch about 1.2 to 1.3 million dollars. Adam will head up the new sales force of about 13 reps after letting about a quarter of the remaining reps go. Also, the word is that they will do away with the Christmas shut down. I think that they figure that this powerhouse is freakin printing money so they don't want to slow the powerhouse down and lose momentum going into the new year.

 

[Anonymous]

Givebacks to save jobs in generics - sign me up

We have no issue with giving back the holiday shutdown but a 10% pay cut under discussion is hard to swallow given that generics unlike strativa is profitable

 

[Anonymous]

We have no issue with giving back the holiday shutdown but a 10% pay cut under discussion is hard to swallow given that generics unlike strativa is profitable

Le pore has been ceo for 8 years and he is clueless about the high cost structure at par. Greg Gilbert and all the other ws analysts continue to note par's high cost structure while watson mylan continue to pull market share from par.PAR has sector leading pay bonus benefits despite poor performance and slipping market share. Par owned the Toprol market and at one time was sole supplier until watson stole massive share as par continues to report declining sales. PAR CAN NOT COMPETE DUE TO HIGH SALARIES, SUPER GENEROUS MANAGEMENT OPTION PACKAGES AND EMPLOYEE BENEFITS

THE DAY OF RECKONING IS FAST APPROACHING

Le pore might be blind, but the shakers are not stupid !

 

[Anonymous]

We have no issue with giving back the holiday shutdown but a 10% pay cut under discussion is hard to swallow given that generics unlike strativa is profitable

WE can live with the paycut if managers do likewise absolutely

 

[Anonymous]

Le pore has been ceo for 8 years and he is clueless about the high cost structure at par. Greg Gilbert and all the other ws analysts continue to note par's high cost structure while watson mylan continue to pull market share from par.PAR has sector leading pay bonus benefits despite poor performance and slipping market share. Par owned the Toprol market and at one time was sole supplier until watson stole massive share as par continues to report declining sales. PAR CAN NOT COMPETE DUE TO HIGH SALARIES, SUPER GENEROUS MANAGEMENT OPTION PACKAGES AND EMPLOYEE BENEFITS

THE DAY OF RECKONING IS FAST APPROACHING

Le pore might be blind, but the shakers are not stupid !

8 years as ceo and still no management action as par deteriorates. Pat will jump over that hoop and cut cut cut

 

[Anonymous]

Le pore has been ceo for 8 years and he is clueless about the high cost structure at par. Greg Gilbert and all the other ws analysts continue to note par's high cost structure while watson mylan continue to pull market share from par.PAR has sector leading pay bonus benefits despite poor performance and slipping market share. Par owned the Toprol market and at one time was sole supplier until watson stole massive share as par continues to report declining sales. PAR CAN NOT COMPETE DUE TO HIGH SALARIES, SUPER GENEROUS MANAGEMENT OPTION PACKAGES AND EMPLOYEE BENEFITS

THE DAY OF RECKONING IS FAST APPROACHING

Le pore might be blind, but the shakers are not stupid !

WELL STATED

 

[Anonymous]

8 years as ceo and still no management action as par deteriorates. Pat will jump over that hoop and cut cut cut

NO pat will get canned (since he canned so many) and then the new ceo will jump that hoop

 

[Anonymous]

It becomes so obvious when you compare the super generous par employee benefits to the new employees coming over from edict anchen pharmas

Le pore is so slow to act but he finally gets it

a

WE have no choice, lets get it done. It beats foreign ownership

 

[Anonymous]

Major news this week....

 

[Anonymous]

Major news this week....

Please share ur insight

 

[Anonymous]

Please share ur insight

Just watch your email.

 

[Anonymous]

haughey gets a promotion after losing cases that cost par over $300M yes 300 million

pc is ok but needs to brush up on mgt 101 and get costs in generics down to competitor levels so par is no longer the highest cost producer in the generic space

watson is undercutting par at every turn as PAR CONTINUES TO OFFER THE HIGHEST SALARIES AND MOST GENEROUS FRINGE BENEFIT PACKAGES IN THE WORLD while productivity continues to LAG for both generics and strativa

 

[Anonymous]

Uhh no they don't.

 

[Anonymous]

8 years as ceo and still no management action as par deteriorates. Pat will jump over that hoop and cut cut cut

Pl has been CEO since nov 2006. That's 5 years.

 

[Anonymous]

I heard the fat lady singing after the email went out. Have fun finding a job fat lady.

 

[Anonymous]

What email

 

[Anonymous]

haughey gets a promotion after losing cases that cost par over $300M yes 300 million

pc is ok but needs to brush up on mgt 101 and get costs in generics down to competitor levels so par is no longer the highest cost producer in the generic space

watson is undercutting par at every turn as PAR CONTINUES TO OFFER THE HIGHEST SALARIES AND MOST GENEROUS FRINGE BENEFIT PACKAGES IN THE WORLD while productivity continues to LAG for both generics and strativa

By a mile